Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Assets: 2017-2024

Historic Assets for Dianthus Therapeutics (DNTH) over the last 6 years, with Dec 2024 value amounting to $374.0 million.

  • Dianthus Therapeutics' Assets rose 63.01% to $577.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $577.4 million, marking a year-over-year increase of 63.01%. This contributed to the annual value of $374.0 million for FY2024, which is 108.47% up from last year.
  • Dianthus Therapeutics' Assets amounted to $374.0 million in FY2024, which was up 108.47% from $179.4 million recorded in FY2023.
  • Over the past 5 years, Dianthus Therapeutics' Assets peaked at $374.0 million during FY2024, and registered a low of $83.1 million during FY2022.
  • Its 3-year average for Assets is $212.2 million, with a median of $179.4 million in 2023.
  • Data for Dianthus Therapeutics' Assets shows a peak YoY surged of 115.86% (in 2023) over the last 5 years.
  • Dianthus Therapeutics' Assets (Yearly) stood at $83.1 million in 2022, then skyrocketed by 115.86% to $179.4 million in 2023, then spiked by 108.47% to $374.0 million in 2024.